Actively Recruiting
INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)
Led by Azienda Ospedaliero-Universitaria di Parma · Updated on 2026-02-17
300
Participants Needed
2
Research Sites
245 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a multicenter, experimental preclinical study conducted on primary samples from patients diagnosed with hematological or solid neoplasms defined as high risk. The study will be prospective, based on the consecutive enrollment of eligible patients at each participating institution.
CONDITIONS
Official Title
INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged one year and over who are referred to the centres involved in the protocol (Azienda Ospedaliero-Universitaria di Parma, University of Parma, University of Perugia and Azienda Ospedali Riuniti Villa Sofia-Cervello of Palermo).
- Patients with an established diagnosis of haematological or solid organ malignancy, including haematological or solid malignancies characteristic of the paediatric age group.
- Patients diagnosed with relapsed, refractory and/or metastatic haematological or solid malignancy.
- Patients may be enrolled regardless of the extent and type of previous therapy.
- Patients may also be enrolled if they are undergoing active treatment at the time of evaluation.
- Patients must have the capacity to understand the investigative nature of the study and provide informed consent in writing.
- For patients under the age of 12 years, consent will be provided by the parent/legal guardian according to international guidelines.
- For patients aged 12 to 17 years, consent will be provided by the patient and the parent/legal guardian according to the mature minor principle.
You will not qualify if you...
- Patients younger than 1 year old
- Patients with active, uncontrolled infections
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
AO Riuniti Villa Sofia-Cervello di Palermo
Palermo, Palermo, Italy, 90146
Actively Recruiting
2
University of Perugia
Perugia, Perugia, Italy, 06123
Actively Recruiting
Research Team
G
Giovanni Roti, Associate Professor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
BASIC_SCIENCE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here